|
7641 |
Sehr gut wirksam und sicher
Enthalten in Der deutsche Dermatologe Bd. 66, 11.9.2018, Nr. 9, date:9.2018: 696
|
|
|
|
7642 |
Sein Handicap akzeptieren - mit funktionell-ästhetischen Prothesen
Enthalten in Orthopädie & Rheuma Bd. 24, 30.8.2021, Nr. 4, date:8.2021: 60-61
|
|
|
|
7643 |
Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis
Enthalten in BMC psychiatry Bd. 17, 8.2.2017, Nr. 1, date:12.2017: 1-28
|
|
|
|
7644 |
Selektive B-Zelldepletion als neue Therapieoption
Enthalten in Psychopraxis. Neuropraxis Bd. 20, 31.8.2017, Nr. 4, date:9.2017: 184-186
|
|
|
|
7645 |
Selektive IgG-Reduktion verringert Symptome
Enthalten in Info Neurologie & Psychiatrie Bd. 23, 22.10.2021, Nr. 10, date:10.2021: 44-45
|
|
|
|
7646 |
Selektive Kostimulationsblockade
Enthalten in Zeitschrift für Rheumatologie Bd. 69, 13.8.2010, Nr. 7, date:9.2010: 601-607
|
|
|
|
7647 |
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
Enthalten in Critical care Bd. 21, 15.8.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
7648 |
Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
Enthalten in BMC psychiatry Bd. 13, 9.10.2013, Nr. 1, date:12.2013: 1-11
|
|
|
|
7649 |
Seltsame Schwarzfärbungen am ganzen Körper
Enthalten in Hautnah / Dermatologie Bd. 34, 12.5.2018, Nr. 3, date:5.2018: 24
|
|
|
|
7650 |
Semaglutid bei nicht alkoholischer Steatohepatitis
Enthalten in Gastronews Bd. 8, 24.6.2021, Nr. 3, date:6.2021: 24-25
|
|
Administration
